Research and Markets (http://www.researchandmarkets.com/research/d97a95/liver_cancer_drug)
has announced the addition of the "Liver
Cancer Drug Pipeline Update 2010" report to their offering.
There are today 136 (113) companies plus partners developing 154 (107)
drugs targeting liver cancer in active development. In addition, the
accumulated number of ceased drugs over the last years amount to another
42 (34) drugs. Liver Cancer Drug Pipeline Update lists all drugs and
gives you a progress analysis on each one of them. Identified drugs are
linked to 104 (75) different targets. These targets are further
categorized on the CD-ROM by 41 (34) classifications of molecular
function and with pathway referrals to BioCarta, KEGG and NetPath.
Figures in brackets are comparative data from last year.
Find and sort drugs by twelve different parameters plus free text search
field. Our dynamic report generator lets you with ease and speed
generate html reports directly in your web browser, whether it is a
single drug profile or an entire search you want have a report of.
How May Drug Pipeline Update Be of Use?